|
Home Up People Publications Basic Research Intellectual Property
| |
|
Applied Research
THE LABORATORY OF R. MALCOLM
BROWN, JR.
Biomedical
Applications |
|
The Future Prospects of
Microbial Cellulose in
Biomedical Applications
Wojciech K. Czaja,
David J. Young,
Marek Kawecki, and
R. Malcolm Brown, Jr.*
Section of Molecular Genetics and Microbiology, University of
Texas at Austin, Austin, Texas 78713, Institute of Technical
Biochemistry, Technical University of Lodz, Stefanowskiego 4/10, Lodz
90-924, Poland, and Center of Burn Healing, Jana Pawla II 2,
Siemianowice l skie,
Poland
Received June 28, 2006
Revised September 8, 2006
Abstract:
Microbial cellulose has proven
to be a remarkably versatile biomaterial and can be used in wide variety
of applied scientific endeavors, such as paper products, electronics,
acoustics, and biomedical devices. In fact, biomedical devices recently
have gained a significant amount of attention because of an increased
interest in tissue-engineered products for both wound care and the
regeneration of damaged or diseased organs.
Due to its unique nanostructure
and properties, microbial cellulose is a natural candidate for numerous
medical and tissue-engineered applications. For example, a microbial
cellulose membrane has been successfully used as a wound-healing device
for severely damaged skin and as a small-diameter blood vessel
replacement. The nonwoven ribbons of microbial cellulose microfibrils
closely resemble the structure of native extracellular matrices,
suggesting that it could function as a scaffold for the production of
many tissue-engineered constructs. In addition, microbial cellulose
membranes, having a unique nanostructure, could have many other uses in
wound healing and regenerative medicine, such as guided tissue
regeneration (GTR), periodontal treatments, or as a replacement for dura
mater (a membrane that surrounds brain tissue). In effect, microbial
cellulose could function as a scaffold material for the regeneration of
a wide variety of tissues, showing that it could eventually become an
excellent platform technology for medicine.
If microbial cellulose can be
successfully mass produced, it will eventually become a vital
biomaterial and will be used in the creation of a wide variety of
medical devices and consumer products.
The full text of this article can be found at http://pubs.acs.org/cgi-bin/abstract.cgi/bomaf6/asap/abs/bm060620d.html
Biomacromolecules,
ASAP Article
10.1021/bm060620d
Web Release Date: December 1,
2006
Copyright © 2006 American Chemical Society
|
|